Skip to main content
Fig. 9 | Acta Neuropathologica Communications

Fig. 9

From: Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Fig. 9

Surfen has no significant effect on lesion size when administered 7 days after LPC injection. a Left sided linear graphic shows treatment schedule, while right sided panels show data for each time point, as well as representative images of lesions in the corpus callosum. b The area of the lesions is plotted against time from LPC injection for groups indicated. Data is shown as mean ± SEM; Scale bars: LPC, LPC + Sham = 300 μm; LPC border = 100 μm, Vehicle/Surfen = 500 μm

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us